These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1386104)

  • 1. In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
    Chabriat H; Levasseur M; Vidailhet M; Loc'h C; Mazière B; Bourguignon MH; Bonnet AM; Zilbovicius M; Raynaud C; Agid Y
    J Nucl Med; 1992 Aug; 33(8):1481-5. PubMed ID: 1386104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseases.
    Prunier C; Tranquart F; Cottier JP; Giraudeau B; Chalon S; Guilloteau D; De Toffol B; Chossat F; Autret A; Besnard JC; Baulieu JL
    Nucl Med Commun; 2001 Nov; 22(11):1207-14. PubMed ID: 11606886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-123-iodo-lisuride SPECT in Parkinson's disease.
    Cordes M; Hierholzer J; Schelosky L; Schrag A; Richter WS; Eichstädt H; Schulze PE; Poewe W; Felix R
    J Nucl Med; 1996 Jan; 37(1):22-5. PubMed ID: 8543995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
    J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic D2 receptor SPECT imaging in Rett syndrome: increase of specific binding in striatum.
    Chiron C; Bulteau C; Loc'h C; Raynaud C; Garreau B; Syrota A; Mazière B
    J Nucl Med; 1993 Oct; 34(10):1717-21. PubMed ID: 8410289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-[123I]-iodolisuride SPET visualizes dopaminergic loss in de-novo parkinsonian patients: is it a marker of striatal pre-synaptic degeneration?
    Müller T; Eising EG; Reiners C; Przuntek H; Jacob M; Kuhn W
    Nucl Med Commun; 1997 Dec; 18(12):1115-21. PubMed ID: 9481757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using 123I-iodolisuride SPET.
    Baulieu JL; Ribeiro MJ; Levilion-Prunier C; Tranquart F; Chartier JR; Guilloteau D; Cottier JP; Besnard JC; Pourcelot L; Autret A
    Nucl Med Commun; 1999 Jan; 20(1):77-84. PubMed ID: 9949416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
    Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography.
    Oyanagi C; Katsumi Y; Hanakawa T; Hayashi T; Thuy Dh; Hashikawa K; Nagahama Y; Fukuyama H; Shibasaki H
    J Neuroimaging; 2002 Oct; 12(4):316-24. PubMed ID: 12380478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
    Hierholzer J; Cordes M; Schelosky L; Richter W; Keske U; Venz S; Semmler W; Poewe W; Felix R
    J Nucl Med; 1994 Dec; 35(12):1921-7. PubMed ID: 7989970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP; Kapucu O; Sokole-Busemann E; van Royen EA; Janssen AG
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2 receptor imaging and measurement with SPECT.
    Brücke T; Wenger S; Asenbaum S; Fertl E; Pfafflmeyer N; Müller C; Podreka I; Angelberger P
    Adv Neurol; 1993; 60():494-500. PubMed ID: 8420177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.
    Baron JC; Mazière B; Loc'h C; Cambon H; Sgouropoulos P; Bonnet AM; Agid Y
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):131-6. PubMed ID: 3485639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors: a comparative study.
    Pellevoisin C; Guilloteau D; Baulieu JL; Loc'h C; Dognon AM; Mauclaire L; Saccavini JC; Besnard JC; Chalon S
    Synapse; 1996 Sep; 24(1):79-86. PubMed ID: 9046079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
    Arnold G; Tatsch K; Kraft E; Oertel WH; Schwarz J
    Mov Disord; 2002 May; 17(3):557-62. PubMed ID: 12112207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.
    van Royen E; Verhoeff NF; Speelman JD; Wolters EC; Kuiper MA; Janssen AG
    Arch Neurol; 1993 May; 50(5):513-6. PubMed ID: 8489409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left-right asymmetry of striatal dopamine D2 receptors.
    Larisch R; Meyer W; Klimke A; Kehren F; Vosberg H; Müller-Gärtner HW
    Nucl Med Commun; 1998 Aug; 19(8):781-7. PubMed ID: 9751933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.
    Martinot JL; Paillère-Martinot ML; Loc'h C; Hardy P; Poirier MF; Mazoyer B; Beaufils B; Mazière B; Allilaire JF; Syrota A
    Br J Psychiatry; 1991 Mar; 158():346-50. PubMed ID: 1827999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
    Brücke T; Podreka I; Angelberger P; Wenger S; Topitz A; Küfferle B; Müller C; Deecke L
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):220-8. PubMed ID: 1671782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.